scPharmaceuticals Inc. (SCPH) - Quarterly Income Statement

Home
SCPH
Financials

5.26 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1
Revenue Numbers are in millions	8.054	6.102	6.096	3.796	1.638	2.063	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	2.352	1.836	1.773	1.079	0.354	0.605	0.12	0.118	0.128	0.102	0.111	0.112	0.109	0.106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	5.702	4.266	4.323	2.717	1.284	1.458	-0.12	-0.118	-0.128	-0.102	-0.111	-0.112	-0.109	-0.106	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0.708	0.699	0.709	0.716	0.784	0.707	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	2.677	2.726	3.338	3.421	2.934	2.116	2.326	3.718	5.142	4.347	4.53	3.694	3.807	4.009	3.745	5.119	5.139	4.146	8.318	4.293	5.496	6.524	3.149	3.896	4.855	4.048	3.716	3.585	4.145	2.885	3.017	3.617	2.611	2.611
General & Administrative Expenses Numbers are in millions	0	1.075	22.992	0	12.096	10.896	7.176	6.277	4.279	2.893	2.191	2.211	2.649	2.732	3.425	3.319	2.537	2.503	2.115	1.996	1.839	2.323	2.074	1.945	5.049	4.651	2.992	1.665	2.374	2.074	0.943	2.16	1.476	1.476
Selling & Marketing Expenses Numbers are in millions	0	16.321	-6.75	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	17.456	17.396	16.242	14.135	12.096	10.896	7.176	6.277	4.279	2.893	2.191	2.211	2.649	2.732	3.425	3.319	2.537	2.503	2.115	1.996	1.839	2.323	2.074	1.945	5.049	4.651	2.992	1.665	2.374	2.074	0.943	2.16	1.476	1.476
Other Expenses Numbers are in millions	-1.189	2.972	2.412	-0.036	0.239	0.99	1.363	-0.022	0.064	0.014	0.017	0.01	0.033	0.255	0.009	0.019	-0.001	-0.031	-0.045	0.083	-0.014	-0.008	0.002	-0.005	-0.011	-0.042	-0.007	0.015	0.057	0.01	0.027	0	0	0
Operating Expenses Numbers are in millions	20.133	20.122	19.58	17.556	15.03	13.012	9.502	9.995	9.421	7.24	6.721	5.905	6.456	6.741	7.17	8.438	7.676	6.649	10.433	6.289	7.335	8.847	5.223	5.841	9.904	8.699	6.708	5.25	6.519	4.959	3.96	5.783	4.078	4.078
Operating Income Numbers are in millions	-14.431	-15.856	-15.257	-14.839	-13.746	-11.554	-9.502	-9.995	-9.421	-7.24	-6.721	-5.905	-6.456	-6.741	-7.17	-8.438	-7.676	-6.649	-10.433	-6.289	-7.335	-8.847	-5.223	-5.841	-9.904	-8.699	-6.708	-5.25	-6.519	-4.959	-3.96	-5.777	-4.087	-4.087
Operating Income Ratio Numbers are in millions	-1.792	-2.598	-2.503	-3.909	-8.392	-5.601	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	-2.659	1.748	1.445	-0.795	0.239	0.344	0.254	-0.167	-0.276	-0.491	0.017	0.01	0.033	0.255	0.009	0.019	-0.001	-0.031	-0.045	0.083	-0.014	-0.008	0.002	-0.005	-0.011	-0.042	-0.007	0.015	0.057	0.01	0.027	-3.307	-0.901	-0.901
Income Before Tax Numbers are in millions	-17.09	-14.108	-13.812	-15.634	-14.154	-11.21	-9.248	-10.162	-9.697	-7.731	-7.318	-6.552	-7.062	-7.102	-7.784	-9.038	-8.295	-7.092	-10.814	-6.207	-7.255	-8.719	-5.1	-5.761	-9.85	-8.732	-6.88	-5.489	-6.536	-4.912	-5.318	-9.084	-4.988	-4.988
Income Before Tax Ratio Numbers are in millions	-2.122	-2.312	-2.266	-4.119	-8.641	-5.434	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0.008	-3.485	-0.272	2.14	1.617	0.514	0.167	0.276	0.491	0.597	0.647	0.606	0.361	0.614	0.6	0.619	0.443	0.381	-0.082	-0.08	-0.128	-0.123	-0.08	-0.054	0.033	0.172	0.239	0.017	-0.047	1.358	0	0	0
Net Income Numbers are in millions	-17.09	-14.108	-13.812	-15.634	-14.154	-12.827	-9.762	-10.329	-9.973	-8.222	-7.318	-6.552	-7.062	-7.102	-7.784	-9.038	-8.295	-7.092	-10.814	-6.207	-7.255	-8.719	-5.1	-5.761	-9.85	-8.732	-6.88	-5.489	-6.536	-4.912	-5.318	-9.084	-4.988	-4.988
Net Income Ratio Numbers are in millions	-2.122	-2.312	-2.266	-4.119	-8.641	-6.218	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.44	-0.36	-0.36	-0.4	-0.37	-0.34	-0.31	-0.38	-0.36	-0.3	-0.27	-0.24	-0.26	-0.26	-0.28	-0.33	-0.36	-0.35	-0.58	-0.33	-0.39	-0.47	-0.27	-0.31	-0.53	-0.47	-0.8	-0.31	-0.58	-0.44	-0.47	-8.52	-5.65	-5.65
EPS Diluted Numbers are in millions	-0.44	-0.36	-0.36	-0.4	-0.37	-0.34	-0.31	-0.38	-0.36	-0.3	-0.27	-0.24	-0.26	-0.26	-0.28	-0.33	-0.36	-0.35	-0.58	-0.33	-0.39	-0.47	-0.27	-0.31	-0.53	-0.47	-0.8	-0.31	-0.58	-0.44	-0.47	-8.52	-5.65	-5.65
EBITDA Numbers are in millions	-14.379	-15.805	-15.117	-14.839	-12.144	-9.249	-7.289	-9.667	-9.122	-7.111	-6.697	-5.773	-6.302	-6.36	-7.127	-8.282	-7.557	-6.361	-10.168	-5.809	-6.797	-8.365	-4.73	-5.317	-9.409	-8.309	-6.544	-5.16	-6.378	-4.886	-3.927	-5.776	-4.085	-4.085
EBITDA Ratio Numbers are in millions	-1.785	-2.59	-2.48	-3.909	-7.414	-4.483	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

scPharmaceuticals Inc.

NASDAQ:SCPH Add to watchlist

NASDAQ:SCPH